Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED BALANCE SHEETS

v3.24.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current Assets:    
Cash and cash equivalents $ 411 $ 2,897
Accounts receivable 294 273
Inventories 2,737 7,070
Prepaid expenses and other current assets 641 890
Total current assets 4,083 11,130
Property and equipment, net 93 174
Other assets 647 148
Total assets 4,823 11,452
Current Liabilities:    
Accounts payable 2,320 2,042
Accrued liabilities 1,317 1,632
Total current liabilities 3,637 3,674
Convertible note payable   457
Warrant liabilities 5,460 8,945
Derivative liability   333
Other liabilities 636 39
Total liabilities 9,733 13,448
Commitments and contingencies (Note 8)
Series B Convertible Redeemable Preferred Stock, par value $0.0001; 375,000 shares authorized as of December 31, 2023; 38,335 shares issued and outstanding as of December 31, 2023 (none as of December 31, 2022); mandatorily redeemable on October 15, 2025 for $3,833,500 247  
Stockholders' Equity/ (Deficit):    
Common stock, par value $0.0001; 200,000,000 shares authorized; 33,356,855 and 712,564 shares issued and outstanding as of December 31, 2023 and 2022, respectively 7 7
Additional paid-in capital 241,878 226,318
Accumulated deficit (247,042) (228,321)
Total stockholders' equity/ (deficit) (5,157) (1,996)
Total liabilities, convertible preferred stock and stockholders' equity/ (deficit) $ 4,823 $ 11,452